A stock's price can fall for many reasons. The company may no longer be performing as it's expected to. The industry or sector could be temporarily out of fashion. Sometimes, a weak market simply pulls good stocks down with it.

As long as the issue isn't fundamental (and long-term), you can still buy low and eventually sell high, even in a toppy market like today's.

Today, we will look at 10 stocks with market caps between $10 billion and $200 billion that have fallen hard in the past year, but that some analysts think are poised for a bounce-back. These companies are in a variety of industries - everything from banking to pharmaceuticals to industrial products to consumer goods.

Clearly, each of these stocks comes with some risk given the bearish drivers that have dragged them down by 20%, 30%, even 40%. But investors should be less concerned about why these stocks fell in the past, and more concerned about whether they realistically can rebound from here. None of these stocks need to reach their old highs for investors to neatly profit - the underlying companies just need to follow through on proposed ways to increase shareholder value.

Here's a look at 10 battered stocks to buy for their recovery potential.

Allergan

Courtesy ec-jpr via Flickr

Market value: $62.3 billion

52-week loss: 20.6%

Just a few years ago, Dublin-based pharmaceutical giant Allergan (, $184.46) had an agreement in principle to merge with American pharma blue chip Pfizer () in a $160 billion deal. But the U.S. government stopped that